Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family. DR4 was recently identified as the receptor for TRAIL. A novel death domain containing receptor for TRAIL was more recently identified and designated DR5, Apo2, TRAIL-R2, TRICK2, or KILLER by several groups independently (1-2). Like DR4, DR5 transcript is widely expressed in normal tissues and in many types of tumor cells. DR5 binds to TRAIL and mediates TRAIL induced cell death. Overexpression of DR5 induces apoptosis and activates NF-kB.

Long Name

TRAIL Receptor 2

Alternate Names

CD262, DR5, TNFRSF10B, TRAILR2

Gene Symbol

TNFRSF10B

Additional TRAIL R2/TNFRSF10B Products

Product Documents for TRAILR2/TNFRSF10B Antibody (118929) [Janelia Fluor® 525]

Product Datasheets

Download Product Datasheets

COA

SDS

Download SDS

Product Specific Notices for TRAILR2/TNFRSF10B Antibody (118929) [Janelia Fluor® 525]

Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations
Reviews

TRAILR2/TNFRSF10B Antibody (118929) [Janelia Fluor® 525]

Novus Biologicals, part of Bio-Techne | Catalog # FAB1540JF525

Key Product Details

Species Reactivity

Applications

Label

Antibody Source

Concentration

View all TRAIL R2/TNFRSF10B Antibodies »

Product Specifications

Immunogen

Specificity

Clonality

Host

Isotype

Applications for TRAILR2/TNFRSF10B Antibody (118929) [Janelia Fluor® 525]

Immunohistochemistry

Western Blot

Formulation, Preparation, and Storage

Purification

Formulation

Preservative

Concentration

Shipping

Stability & Storage

Background: TRAIL R2/TNFRSF10B